LONDON (Alliance News) - GlaxoSmithKline PLC Friday announced that a group of executives, including Chief Executive Officer Andrew Witty, had received shares after share options they had been awarded had vested.
The following executives share options from the company's 2011 performance share plan awards vested as follows:
| Awards which have vested
| Awards which have lapsed
| ||
Ordinary Shares | ADS | Ordinary Shares | ADS | |
Sir Andrew Witty* | 196,634 |
| 297,421 |
|
Mr S Dingemans* | 90,845 |
| 137,408 |
|
Dr M Slaoui* |
| 68,345 |
| 103,376 |
Mr S Bicknell | 23,596 |
| 35,690 |
|
Ms D Connelly |
| 28,553 |
| 43,188 |
Mr A Hussain | 57,952 |
| 87,656 |
|
Mr W Louv |
| 19,926 |
| 30,139 |
Mr D Redfern | 33,034 |
| 49,966 |
|
Ms C Thomas | 46,405 |
| 70,191 |
|
Mr D Troy |
| 36,451 |
| 55,134 |
Mr P Vallance | 66,855 |
| 101,123 |
|
* denotes an Executive Director
The following executives share options from the company's 2011 deferred annual bonus awards vested as follows:
| Nil Cost Option over Ordinary Shares
| Conditional Awards of ADSs/Co-Investment Shares (ADSs) |
Vested | Vested/Released | |
Sir Andrew Witty* | 37,182 |
|
Dr Moncef Slaoui* |
| 21,848 |
Mr S Bicknell | 7,912 |
|
Ms D Connelly |
| 5,280 |
Mr W Louv |
| 2,392 |
Mr D Redfern | 8,837 |
|
Ms C Thomas | 1,967 |
|
Mr D Troy |
| 10,950 |
Mr P Vallance | 17,569 |
|
* Denotes an Executive Director
The following executives also saw matching shares award under the company's 2011 deferred annual bonus awards as follows:
| Nil Cost Option over Ordinary Shares
| Conditional Awards of ADSs/Co-Investment Shares (ADSs) |
Vested | Vested/Released | |
Sir Andrew Witty* | 37,182 |
|
Dr Moncef Slaoui* |
| 21,848 |
Mr S Bicknell | 7,912 |
|
Ms D Connelly |
| 5,280 |
Mr W Louv |
| 2,392 |
Mr D Redfern | 8,837 |
|
Ms C Thomas | 1,967 |
|
Mr D Troy |
| 10,950 |
Mr P Vallance | 17,569 |
|
* Denotes an Executive Director
The following executives, who have since been appointed persons discharging managerial responsibilites, share options from the company's 2011 performance share plan awards vested as follows:
| Awards vesting | Awards lapsed |
Ordinary Shares | Ordinary Shares | |
Mr R Connor | 4,260 | 2,224 |
Mr P Thomson | 6,868 | 6,868 |
Ms E Walmsley | 76,309 | 14,104 |
Mrs V Whyte | 6,868 | 6,868 |
| Awards vesting | Awards lapsed |
ADSs | ADSs | |
Mr James Ford | 3,923 | 3,923 |
Finally, K Thomson, a person connected to Senior Vice President of Global Communications Philip Thomson received 1,420 shares as options from the company's 2011 Performance Share Plan vested.
Shares in GlaxoSmithKline closed up 0.7% at 1,664.50 pence Friday afternoon.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @hanassallnews
Copyright © 2014 Alliance News Limited. All Rights Reserved.